Drugs / Anti-Trop2 CAR-NK cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06454890 | Aug 2024 → Jul 2026 overdue | non-small cell lung carcinoma | Henan Cancer Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-Trop2 CAR-NK cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06454890 ↗ |
| Modality | Cell therapy | “anti-Trop2 U-CAR-NK Cells Therapy” NCT06454890 ↗ |
| Route | Other | “Trop2 CAR-NK infusion” NCT06454890 ↗ |